# Traitomic

> Carlsberg-origin plant and microbial trait discovery business using FIND-IT to select genetic variants without direct genome editing.

## Why it is interesting

A €20M Series A led by Sofinnova on November 17 funds a non-GM route to valuable plant and microbial variants, with biological material delivery to customers rather than a consumer seed marketplace. The financier and deal adviser corroborate its first external financing.

## Profile

- **Latest funding:** Series A — €20M (November 17, 2026)
- **Latest known valuation:** Not publicly disclosed
- **Total disclosed equity funding:** Not publicly disclosed
- **Stage:** series-a
- **Status:** private
- **Industries:** N/A
- **Coverage:** full
- **Last updated:** 2026-11-18
- **Latest funding investors:** Sofinnova Partners, Export and Investment Fund of Denmark (EIFO), Footprint Firm, PSV Hafnium, Nordic Foodtech VC, SVG Ventures

## Key facts

- €20M Series A disclosed 17 November 2026, led by Sofinnova Partners with EIFO, Footprint Firm, PSV Hafnium, Nordic Foodtech VC and SVG Ventures participating.
- ABG Sundal Collier says it advised Carlsberg Group on the transaction, corroborating the issuer's disclosure.
- Company materials describe targeted genetic screening, isolation and biological-material transfer—not CRISPR editing of customer varieties.
- Third-party coverage reports 116 traits delivered to 47 customers across 32 organisms; these remain reported operating metrics, not audited revenue or successful downstream market launches.
- Traitomic originated from Carlsberg's breeding research; separate Carlsberg brewing IP and licence scope should not be inferred beyond public statements.

## Funding history

- Series A · €20M · November 17, 2026
  Source: https://www.abgsc.com/traitomic-capital-raise/

## Investors in our directory

- https://venturecapitaltracker.com/fund/sofinnova-partners

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)
**Last updated:** November 18, 2026

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

---
Source: https://venturecapitaltracker.com/startup/traitomic-carlsberg-find-it
